Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers are increasingly being used to support a diagnosis of Alzheimer’s disease (AD). Their clinical utility for differentiating AD from non-AD neurodegenerative dementias, such as dementia with Lewy bodies (DLB) or frontotemporal dementia (FTD), is less we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Paterson, Ross W., Slattery, Catherine F., Poole, Teresa, Nicholas, Jennifer M., Magdalinou, Nadia K., Toombs, Jamie, Chapman, Miles D., Lunn, Michael P., Heslegrave, Amanda J., Foiani, Martha S, Weston, Philip S. J., Keshavan, Ashvini, Rohrer, Jonathan D., Rossor, Martin N., Warren, Jason D., Mummery, Catherine J., Blennow, Kaj, Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861624/
https://ncbi.nlm.nih.gov/pubmed/29558979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0361-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados